Chemzin Biotox Research Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 3.50 M
- Company Age 1 Year 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.47 Cr
About Chemzin Biotox Research Institute
Chemzin Biotox Research Institute Private Limited (CBRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 August 2023 (One year and five months 11 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹2.47 Cr.
Anand Uppal and Vijay Uppal serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U86905CH2023PTC045262
-
Company No.
045262
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2023
-
Date of AGM
16 Dec 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Chemzin Biotox Research Institute?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Uppal
|
Director | 30-Aug-2023 | Current |
|
Vijay Uppal
|
Director | 30-Aug-2023 | Current |
Financial Performance of Chemzin Biotox Research Institute.
Enhance accessibility to Chemzin Biotox Research Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemzin Biotox Research Institute?
Unlock access to Chemzin Biotox Research Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vadsp Pharma Care Private LimitedAnand Uppal and Vijay Uppal are mutual person
-
Chemzin Graphics Private LimitedAnand Uppal and Vijay Uppal are mutual person
-
Ulabs Private LimitedAnand Uppal and Vijay Uppal are mutual person
-
Biotrendz Medicament Private Limited
Anand Uppal and Vijay Uppal are mutual person
Charges (Loans)
₹2.47 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2024 | Axis Bank Limited | ₹2.47 Cr | Open |
How Many Employees Work at Chemzin Biotox Research Institute?
Unlock and access historical data on people associated with Chemzin Biotox Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemzin Biotox Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemzin Biotox Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.